Saturday 17 October 2026 Export REGN’s income statement to Excel — free account

Regeneron Pharmaceuticals, Inc.

Regeneron Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $14.3 billion, up 0.99% from fiscal 2024. In the quarter to June 2026, revenue grew 16.7%, EPS fell 4.68%, free cash flow fell 29.3% and total debt fell 26.6%, each against the same quarter a year earlier. Member of the S&P 500 and Nasdaq 100; revenue growth for three consecutive years.

790.74 5.60 −0.70%

Follow REGN

Alert me

Market cap: $82.0B
P/E: 18.9×
Fwd P/E: 16.5×
Dividend yield: 0.47%
F-score: 5/9
Altman Z: 7.49
Beneish M: −2.53
Dividend safety: 77/100

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
ROE Full definition →	+8 more TTM periods Free account	15.19%	14.87%	14.55%	14.04%
Piotroski F-Score Full definition →		5	5	5	6
ROA Full definition →		11.80%	11.50%	11.28%	10.83%
ROIC Full definition →		9.14%	8.82%	9.20%	9.34%
Return on Tangible Assets Full definition →		24.67%	24.00%	24.08%	23.56%
Average Days of Receivables Full definition →		145.69	146.10	140.21	154.26
Free Cash Flow per Share Full definition →		37.46	36.00	36.45	34.78
Free Cash Flow Full definition →		3,881.00	3,765.20	3,791.00	3,575.20
Capital Expenditures Full definition →		(1,190.00)	(1,213.70)	(1,221.70)	(1,106.10)
Other line items
Cash ROIC Full definition →		9.22%	8.85%	8.99%	8.58%
Accounts Receivable Turnover Full definition →		2.42	2.40	2.64	2.55
Accounts Payable Turnover Full definition →		2.97	2.43	2.66	2.50
Inventory Turnover Full definition →		0.66	0.67	0.73	0.75
Average Days of Payables Full definition →		158.49	163.15	162.59	179.90
Days of Inventory on Hand Full definition →		570.67	556.14	491.29	478.62
Tax Rate Full definition →		(0.11)	(0.14)	(0.14)	(0.16)
Research and Development Expense of Revenue Full definition →		39.56%	40.79%	40.66%	40.40%
Selling, General and Administrative Expense of Revenue Full definition →		19.07%	18.82%	18.20%	17.65%
Share Based Compensation of Revenue Full definition →		7.36%	6.93%	6.67%	6.35%
Interest Coverage Full definition →		87.61	81.69	75.61	69.37
Operating CF/Net income Full definition →		1.11	1.11	1.13	1.08
Depreciation/Fixed assets Full definition →		0.11	0.11	0.10	0.10
Capex/Depreciation Full definition →		(2.27)	(2.23)	(2.26)	(2.09)
Revenue per Share Full definition →		137.53	137.12	143.46	151.12
Operating CF per Share Full definition →		48.95	47.60	48.20	45.54
Capex per Share Full definition →		(11.49)	(11.60)	(11.75)	(10.76)
Capex to Sales Full definition →		0.08	0.08	0.08	0.07

Show all line items

Columns are period end dates

Stockrow Weekly